Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 89,375 shares at $1.28 ($114K) on 2026-01-20, disclosed to the SEC on 2026-01-22.
Scheduled sale ($114k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |
| PLRX | SELL | 2023-04-03 | $1.9M | — | Filing → |